On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.

 

 

 

On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.
&nbsp;
&nbsp;
&nbsp;

Fill your workday afternoon with keen conversations that will inspire and inform with a slew of programs from Eco Money & Money in the Market to What’s Trending. 

Get your daily review of market movements in Market View and Money in the Market that explores important investment news that might affect movements for the rest of the day.

Fill your workday afternoon with keen conversations that will inspire and inform with a slew of programs from Eco Money &amp; Money in the Market to What’s Trending. Get your daily review of market movements in Market View and Money in the Market that explores important investment news that might affect movements for the rest of the day.

Advertisement